Skip to main content
Download PDF

Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer

BMC Medical Genomics volume 17, Article number: 26 (2024) Cite this article

Abstract

Background

To compare the expression levels of long non-coding RNA (lncRNA) and messenger RNA (mRNA) in pre-receptive endometrium between patients with Polycystic Ovary Syndrome (PCOS)and normal ovulation undergoing in vitro fertilization-embryo transfer (IVF-ET).

Methods

Endometrial tissues were collected with endometrial vacuum curette in pre-receptive phase (3 days after oocytes retrieval) from PCOS and control groups. LncRNAs and mRNAs of endometrium were identified via RNA sequencing and alignments. A subset of 9 differentially expressed lncRNAs and 11 mRNAs were validated by quantitative reverse transcription polymerase chain reaction(qRT-PCR)in 22 PCOS patients and 18 ovulation patients. The function of mRNAs with differential expression patterns were explored using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG).

Results

We found out 687 up-regulated and 680 down-regulated mRNAs, as well as 345 up-regulated and 63 down-regulated lncRNAs in the PCOS patients in contrast to normal ovulation patients. qRT-PCR was used to detect the expression of 11 mRNAs, and validated that the expression of these 6 mRNAs CXCR4, RABL6, OPN3, SYBU, IDH1, NOP10 were significantly elevated among PCOS patients, and the expression of ZEB1 was significantly decreased. qRT-PCR was performed to detect the expression of 9 lncRNAs, and validated that the expression of these 7 lncRNAs IDH1-AS1, PCAT14, FTX, DANCR, PRKCQ-AS1, SNHG8, TPT1-AS1 were significantly enhanced among PCOS patients. Bioinformatics analysis showed that differentially expressed genes (DEGs) involved KEGG pathway were tyrosine metabolism, PI3K-Akt pathway, metabolic pathway, Jak-STAT pathway, pyruvate metabolism, protein processing in endoplasmic reticulum, oxidative phosphorylation and proteasome. The up-regulation of GO classification was involved in ATP metabolic process, oxidative phosphorylation, RNA catabolic process, and down-regulation of GO classification was response to corticosteroid, steroid hormone, and T cell activation.

Conclusion

Our results determined the characteristics and expression profile of endometrial lncRNAs and mRNAs in PCOS patients in pre-receptive phase, which is the day 3 after oocytes retrival. The possible pathways and related genes of endometrial receptivity disorders were found, and those lncRNAs may be developed as a predictive biomarker of endometrium in pre-receptive phase.

Peer Review reports

Background

Polycystic ovary syndrome (PCOS) is a common ovulation disorder in women of reproductive age. This syndrome causes infertility, insulin resistance, obesity, endometrial hyperplasia, and cardiovascular problems. There are differences in endometrium between PCOS women and healthy controls [1]. Endometrial components are responsible for low fertility and poor pregnancy outcomes in women.

A number of clinical and biochemical factors associated with PCOS could potentially undermine the function of endometrium during pre-receptive, receptive and post-receptive phases [1,2,3]. From a number of interventions to improve endometrial receptivity, there are substantial evidence that endometrial dysfunction increases the risk of pregnancy complications in women with PCOS [4]. It is speculated that the clinical characteristics of the PCOS patients may contribute to dysregulated sex hormone receptor expression and insulin resistance, as well as chronic inflammation, and abnormal vascularity and immune function in the endometrium. Endometrial dysfunction, abnormal trophoblast infiltration, and placental formation in women with PCOS can lead to miscarriage and pregnancy complications. The mechanisms of endometrial dysfunction in patients with PCOS are not well understood.

Long non-coding RNAs (lncRNAs) are a diverse class of RNAs which are more than 200 nucleotides in length and play important role in numerous biological processes. There are some preliminary studies on the role of lncRNAs in PCOS. It was reported that the expression of lncRNA ENST00000550337.1 in PCOS patients was significantly higher than the control group [5]. The lncRNA ENST00000550337.1 in peripheral blood is mainly participate in glucose metabolism. In a Chinese preliminary study, long non-coding RNA H19 was linked to PCOS [6]. In addition, Zhang et al. found that lncRNA CD36-005 may regulated mRNAs related to endometrium function in endometrial stromal cells of PCOS rat model [7]. LncRNA CD36-005 was significantly up-regulated in the ovaries and uterus of PCOS rat model. Moreover, lncRNA CD36-005 overexpression could change the expression of mRNAs in endometrial stromal cells of rat PCOS model, which participate in many biological processes [7]. However, there are few studies focused on the function of lncRNA in the pathogenesis of endometrial in PCOS patients. Hundreds of differentially expressed genes (DEG)s have been identified in the endometrium of PCOS patients during WOI [8,9,10,11]. Endometrium is a dynamic tissue; it undergoes cyclic changes under the control of steroid hormone. Studies reported on the transcriptomic profiling of endometrium across the menstrual cycle of natural cycle [12, 13] and COS cycles [14,15,16]. According to the receptivity of the endometrium to the embryo, the secretory phase can be divided into pre-receptive, receptive, and post-receptive endometrium. However, there have been no reports of DEGs in pre-receptive endometrium of PCOS patients after receiving COS. Therefore, this study was to investigate the different expression levels of lncRNA and mRNA in pre-receptive endometrium between PCOS patients and normal ovulation undergoing IVF-ET.

Materials and methods

Ethics statement

PCOS patients and patients with normal ovulation underwent IVF/ICSI-ET at our department were enrolled from October 2019 to March 2021. This study was approved by the institutional review board of the Second Hospital of Hebei Medical University (Ethics No. 2018-R028).

IVF-ET protocol and patient recruitment

40 patients (22 PCOS patients and 18 patients with normal ovulation) underwent IVF/ICSI-ET were enrolled. PCOS was diagnosed by the Rotterdam consensus. Flexible GnRHant protocol was applied for all the included patients. COS was started from day 2–3 of menstrual bleeding or withdrawal bleeding. Recombinant FSH (r-FSH; GonalF, Switzerland; Merck, Serono, China; Pouliquen, Merck Sharp & Dohme, China; Vermont, IBSA, China) and/or human menopausal gonadotropin (HMG; Livzon, China, or Menopur, Hui Ling, China) were used for COS. GnRHant 0.25 mg was used when the leading follicle reached 14 mm or serum estrogen level exceed 200ng/mL [17]. When ≥ 3 dominant follicles reached 17 mm in diameter, 250ug recombinant hCG (r-hCG) (r-HCG; Ovitrelle, Switzerland; Merck Serono) was used for trigger. Oocyte retrieval was performed 35.5-36.5 h after hCG administration. Patients who did not receive fresh embryo transfer due to mild or moderate OHSS were included in our study. In addition, patients with the progesterone level exceed 1.5ng/ml or the endometrium thickness under 7 mm in the trigger day was excluded. From the morning of the oocyte pickup day, 90 mg progesterone gel (Crinone, Merck Serono, Watford, UK) was administered.

Endometrium collection

Endometrium was collected in 3 patients in both groups on day 3 after oocyte retrieval. Each endometrial tissue sample was randomly selected from PCOS group and normal ovulation group for RNA extraction. The patient assumed the lithotomy position on the operating table after emptying the bladder. We used one-off endometrium suction tube to aspirate endometrial tissue. In order to prevent infection, antibiotics were given for 3 days after the surgery. Bathing and intercourse were forbidden for 2 weeks.

RNA isolation and RNA-seq

Total RNA was extracted from 100 mg of endometrial samples by homogenization with 1 ml of TRIzol Reagent (Invitrogen, Carlsbad, CA). The concentration was determined using the Qubit RNA assay kit in the Qubit 2.0 Flurometer (Life Technologies, Carlsbad, CA, USA). The RNA integrity was assessed using Agilent Bioanalyzer 2100 (Agilent Technologies). All RNA samples were stored at -80 °C for further analysis when the ratio of absorbance at 260 and 280 nm was between 1.8 and 2.2.

After removing ribosomal RNA, nucleotides were used to build a chain specific library [18]. Firstly, the RNA was fragmented into 250-300 bp fragments. Single-strand cDNA sythesis was conducted using fragmented RNA templates and random oligonucleotide primers. After that, the RNA templates were removed by RNase H-mediated degradation. Then complementary DNA strand was made using dNTP substrates, forming double-stranded DNA after adenylation of the 3’ ends and purification. cDNA of about 200 bp were screened using AMPure XP beads. After degradation of strands containing U with USER enzyme, PCR amplification was performed to obtain the library. A final assessment of library quality was conducted using the Agilent Bioanalyzer 2100, and NDEX-coded samples were clustered using the TruSeq PE Cluster Kit v3-cBot-HS (Illumia). Illumina Hiseq 4000 was used to sequence the clustered libraries and generate paired-end reads of 150 bp. The Novogene Co. LTD, Beijing, China performed all the RNA-Seq and data collection.

RNA-seq data and enrichment analysis

The genome comparison of clean reads to the genome or transcriptome is the basis of subsequent analysis. The RNA-Seq sequencing data were analyzed by Hisat2 software. We use Cuffmerge software to merge the transcripts obtained from sample stitching, remove the transcripts whose chain direction is uncertain and the transcript length is less than 200nt. Next, we use Cuffcompare software to compare with known databases and filter out known transcripts from databases. Finally, the coding potential of the selected transcripts was predicted, and Novel_lncRNA and Novel_mRNA were obtained. By referring to HGNC, the newly screened lncRNAs are divided into four types: antisense, lincRNA, sense overlapping, and sense intronic, based on the position relationship of known mRNAs. The network flow algorithm (StringTie) was applied to splice and quantify the transcripts and genes [19]. Cuffdiff or edgeR software was used for the differential gene expression. Padj ≤ 0.05 was selected as the significantly differentially expressed. Through the significant enrichment of pathway, we can explore the main biochemical metabolic pathways and signal transduction pathways involved in differentially expressed genes. We adopt clusterProfiler (http://www.bioconductor.org/packages/release/bioc/html/clusterProfiler.html) and used widely annotated gene databases GO and KEGG to analysis the pathway enrichment of differential genes. GO (Gene Ontology) is a comprehensive database describing gene functions, which can be categorized into molecular function, biological process and cellular component. KEGG (Kyoto Encyclopedia of Genes and Genomes) is a comprehensive database integrating genomic, chemical and system function information [20].

Construction of lncRNA/mRNA interaction network

We constructed lncRNA-mRNA network using Cytoscape3.6.1 to investigate their interactions. Different shapes represent different RNA types. Pearson correlation coefficient was calculated with a significance threshold of R ≥ 0.95 or R ≤ − 0.95 to evaluate the relationship between lncRNAs and mRNAs. Significantly correlated pairs of lncRNA-mRNA were selected to draw the network.

qRT-PCR

To verify the sequencing results, 22 PCOS patients and 18 ovulating patients were selected, and the expressions of 9 lncRNAs and 11 mRNAs were verified by qRT-PCR. After total RNA was extracted, cDNA was generated by reverse transcription. cDNA synthesis of lncRNA and mRNA according to the vendor’s instructions of the MonAmp™ Reverse Transcription Kit. The expression level of lncRNA and mRNA was evaluated by qRT-PCR using MonAmp™ ChemoHS qPCR Mix in a 10 µl reaction system, including 5 µl MonAmp™ ChemoHS qPCR Mix, 1 µl cDNA, 0.5 µl forward/reverse primers (10µmol/L), and 3.5 µl triple distilled water. The specific quantitative primers were designed using oligo7 software and synthesized by Sangon Biotech (Shanghai, China, Table 1). The cycling program was pre-denaturation: 95 °C, 10 min, denaturation: 95 °C, 10s, annealing and extension: 60 °C, 30s, repeat for 40 cycles. After 2−ΔΔCT analysis, the expression levels were normalized to β-actin levels. Each sample had three individual technical replicates.

Table 1 Primer sequences for qRT-PCR.
Full size table

Statistical analysis

Clinical analyses were calculated by SPSS 20.0 (IBM Corp, USA). Results were expressed as mean ± SD. Statistical comparison between the PCOS and the control group was performed by t-test for normal distribution. Unpaired-test and the Mann-Whitney U test were conducted for continuous variables. Categorical variables were used by chi-squared tests or Fisher’s exact tests. P < 0.05 was considered statistically significant.

Results

Clinical characteristics of participants

The clinical characteristics of patients were detailed in Table 2. There were no difference in age and BMI between PCOS patients and ovulation patients. The level of FSH, E2 and T had no difference between the two groups. PCOS patients had higher basal LH. There were no significant differences in HOMA-IR, occytes retrival and thickness of endometrium between the two groups.

Table 2 The baseline characteristics of participants
Full size table

Differentially expression profiles of lncRNAs and mRNAs in pre-receptive endometrium of PCOS and ovulation groups

To investigate the expression profiles of lncRNAs and mRNAs in endometrium with PCOS patients, 6 women (3 with PCOS and 3 matched ovulation patients) were recruited and endometrium was collected on 3 days after oocytes retrival for RNA-seq analysis. RNA-seq results showed that the expression patterns of lncRNAs and mRNAs in PCOS patients were different from those in the controls. Differentially expressed genes (DEGs) of PCOS were calculated using the data of GSE26787, and then re-annotated as differentially expressed mRNAs (DEMs) and lncRNAs (DELs).Topological analysis determined the key mRNAs and lncRNAs with the highest centroid. There were 687 up-regulated mRNAs and 680 down-regulated mRNAs (log2FC ≥ 1.0 and Padj ≤ 0.05), 345 up-regulated lncRNAs and 63 down-regulated lncRNAs (log2FC ≥ 1.5 and Padj ≤ 0.05) in the PCOS patients. Hierarchical clustering analysis showed the overview of mRNAs and lncRNAs expression (Fig. 1A,B). The volcano plots displayed the variation in mRNAs and lncRNAs expression between PCOS and Control groups (Fig. 1C,D). The names of the top 20 up-regulated and 20 down-regulated mRNAs and lncRNAs with differential expressed were shown in Tables 3 and 4 respectively. ANO3 was the most significantly up-regulated mRNA with a log2FC of 6.65. The expression of PAEP mRNA was down-regulated most significantly, with a log2FC of -6.31. For lncRNAs, the most up-regulated lncRNAs was AC122108.1 with a log2FC of 7.66. The most down-regulated lncRNAs was AC104072.1 with a log2FC of -3.66.

Fig. 1
figure 1

lncRNA and mRNA expression profile of endometrium between PCOS and control samples. (A) Hierarchical cluster heat map of mRNA expression in PCOS patients and controls. (B) Hierarchical cluster heat map of lncRNA expression in PCOS patients and controls. Red and blue represent up- and down- regulated genes respectively. (C) Volcano plot of differentially expressed mRNAs between PCOS patients and controls. (D) Volcano plot of differentially expressed lncRNAs between PCOS patients and controls. The orange and blue plots represent the statistically significantly up- and down-expressed mRNA and lncRNA respectively

Full size image
Table 3 Top 20 up-regulated and down-regulated mRNAs in PCOS compared with control
Full size table
Table 4 Top 20 up-regulated and down-regulated lncRNAs in PCOS compared with control
Full size table

Prediction of gene phenotypes based on GO annotations and KEGG pathways

We used GO and KEGG pathway enrichment analyses to investigate the potential functions of differentially expressed mRNAs. The top 20 up- and 20 down-GO annotations on biological processes were shown in Fig. 2A,B. The up-regulation of GO classification was involved in protein targeting to membrane, protein targeting to ER, establishment of protein localization to membrane, RNA catabolic process, protein localization to endoplasmic reticulum, ATP metabolic process and oxidative phosphorylation. The down-regulation of GO classification was T cell activation, extracellular matrix organization, extracellular structure organization, response to steroid hormone, T cell differentiation, regulation of leukocyte differentiation, response to corticosteroid, response to glucocorticoid, sensory perception of taste, negative regulation of humoral immune response. We found that response to corticosteroid, steroid hormone, and glucocorticoid related GO terms were enriched. The T cell activation and regulation of inflammatory response related GO terms were enriched (Fig. 3A). Common genes in GO terms for alpha-bata T cell activation, response to steroid hormone, response to glucocorticoid, calcium ion import and cellular response to steroid hormone stimulus were ZFP36, STC1, SLIT2, SCGB2A2, NR4A1,GRIP1, FOXO1, FOS, ERRFI1,CTSV,CDK7, RORA, ANXA1(Fig. 3B).

Fig. 2
figure 2

GO analysis of differentially expressed mRNAs in PCOS patients and controls. (A) The top 20 up GO terms for the different expressed mRNA in women with PCOS versus a control group. (B) The top 20 down GO terms for the different expressed mRNA in women with PCOS versus a control group. The left side represents the annotation terms

Full size image
Fig. 3
figure 3

Weighted gene co-expression network analysis of differentially expressed genes associated with PCOS patients. (A) Corticosteroid, steroid hormone, and glucocorticoid related GO terms were enriched. T cell activation and regulation of inflammatory response related GO terms were enriched. (B) Common genes in GO terms for alpha-bata T cell activation, response to steroid hormone, response to glucocorticoid, calcium ion import and cellular response to steroid hormone stimulus were analyzed and enriched

Full size image

Bio-informatics analysis showed that DEGs involved up-regulated KEGG [20] pathway (Fig. 4A) were thermogenesis, ribosome, retrograde endocannabinoid signaling, pyruvate metabolism, protein processing in endoplasmic reticulum, oxidative phosphorylation and metabolic pathway. DEGs involved down-regulated KEGG [20] pathway (Fig. 4B) were vascular smooth muscle contraction, tyrosine metabolism, PI3K-Akt signaling pathway, metabolic pathway, Jak-STAT signaling pathway, ECM-receptor interaction, complement and coagulation cascades, cell adhesion molecules (CAMs).

Fig. 4
figure 4

KEGG pathway analysis of differentially expressed mRNAs in PCOS patients and controls. (A) The top 20 up KEGG terms for the different expressed mRNA in women with PCOS versus a control group. (B) The top 20 down KEGG terms for the different expressed mRNA in women with PCOS versus a control group. The horizontal axis represents the p value, and the vertical axis represents the pathway name. The size of the dot indicates the number of differentially expressed genes in the pathway, and the color of the dot corresponds to the different–log10(p-value)

Full size image

Analysis of lncRNA-mRNA co-expression profiles in pre-receptive endometrium of patients with PCOS

In order to identify the associated lncRNA-mRNA network and lncRNA biomarkers for predicting endometrial receptivity, we investigated the gene expression of six key Go terms (Fig. 5). We also further studied the differential lncRNA-mRNA co-expression network to reveal the potential regulatory roles of lncRNAs in endometrium of PCOS patients. Base on the up-regulation of GO classification, we analyzed the co-expression module of ATP metabolic process related mRNA and differentially expressed lncRNAs, the co-expression module of oxidative phosphorylation related mRNA and differentially expressed lncRNAs, the co-expression module of RNA catabolic process related mRNA and differentially expressed lncRNAs (Fig. 6A-C). Base on the down-regulation of GO classification, we analyzed the co-expression module of the co-expression module of response to corticosteroid related mRNA and differentially expressed lncRNAs, the co-expression module of response to steroid hormone related mRNA and differentially expressed lncRNAs, the co-expression module of T cell activation related mRNA and differentially expressed lncRNAs (Fig. 7A-C).

Fig. 5
figure 5

The gene expression of six key Go terms. The top row represents the down GO terms, and the the lower row represents the up- GO terms

Full size image
Fig. 6
figure 6

Analysis of lncRNA-mRNA co-expression profiles in pre-receptive endometrium of patients with PCOS. (A-C) The up-regulation of GO classification. Blue plots represent lncRNA, and orange plots represent ATP metabolic process related mRNA, oxidative phosphorylation related mRNA and RNA catabolic process related mRNA, respectively

Full size image
Fig. 7
figure 7

Analysis of lncRNA-mRNA co-expression profiles in pre-receptive endometrium of patients with PCOS. (A-C) The down-regulation of GO classification. Blue plots represent lncRNA, and orange plots represent response to corticosteroid related mRNA, response to steroid hormone related mRNA and T cell activation related mRNA, respectively

Full size image

Identification and validation of differentially expressed mRNAs and lncRNAs in pre-receptive endometrium of PCOS patients

The identified candidate mRNAs were assayed by qRT-PCR on a sample set of 40 patients (22 PCOS patients and 18 ovulation patients). As shown in Fig. 8A, the expression levels of 6 mRNAs CXCR4, RABL6, OPN3, SYBU, IDH1, NOP10 were significantly higher on 3 days after oocytes retrival in endometrium of PCOS than those in controls. The expression of ZEB1 was significantly decreased in endometrium of PCOS patients. The expression of DKK1, ANXA1, STC1 and CST4 was not statistically significant. qRT-PCR was performed to detect the expression of 9 lncRNAs, and validated that the expression of these 7 lncRNAs IDH1-AS1, PCAT14, FTX, DANCR, PRKCQ-AS1, SNHG8, TPT1-AS1 were significantly elevated in endometrium of PCOS patients. These results suggest that lncRNAs IDH1-AS1, PCAT14, FTX, DANCR, PRKCQ-AS1, SNHG8 and TPT1-AS1 may play a vital role in embryo pre-implantation. The expression of TRPM2-AS and DCST1-AS1 was not statistically significant (Fig. 8B).

In conclusion, the changes in the expression of lncRNAs (IDH1-AS1, PCAT14, FTX, DANCR, PRKCQ-AS1, SNHG8, TPT1-AS1)and mRNAs (CXCR4, RABL6, OPN3, SYBU, IDH1, NOP10) may possibly affect endometrial function in patients with PCOS before the implantation window, probably resulting in implantation failure of the embryo.

Fig. 8
figure 8

Identification and validation of differentially expressed mRNAs and lncRNAs in pre-receptive endometrium of PCOS patients. (A) The 11 key mRNAs were assayed by qRT-PCR on a sample set of 22 PCOS patients and 18 controls. (B) The 9 key lncRNAs were assayed by qRT-PCR on a sample set of 22 PCOS patients and 18 controls. *P < 0.05. **P < 0.01. ***P < 0.001 versus control group. NS: not significant, P > 0.05

Full size image

Discussion

The typical pathophysiological change of PCOS, chronic anovulation, may impact endometrial function and morphology, leading to implantation failure, miscarriage, endometrial hyperplasia and even carcinoma [21]. However, the underlying mechanisms have not yet been thoroughly explored. In this study, we determined differentially expressed lncRNAs and mRNAs in pre-receptive endometrium between PCOS and control women by RNA-seq. Our study was the first to examine the pathophysiology changes of endometirum in PCOS using genome-wide expression profiles on 3 days after oocyte retrieval, which is the time of cleavage embryo transfer. We uncovered that 687 up-regulated mRNAs and 680 down-regulated mRNAs, 345 up-regulated lncRNAs and 63 down-regulated lncRNAs were significant differential expression in the PCOS patients, of which 9 lncRNAs and 11 mRNAs were validated by qRT-PCR. The expressions of 6 mRNAs (CXCR4, RABL6, OPN3, SYBU, IDH1, and NOP10) were significantly elevated in endometrium of PCOS patients. The expressions of 7 lncRNAs (IDH1-AS1, PCAT14, FTX, DANCR, PRKCQ-AS1, SNHG8, and TPT1-AS1) were significantly elevated in endometrium of PCOS patients. These differentially expressed lncRNAs and mRNAs may regulate endometrial receptivity and predicted their functions.

This study identified lncRNA biomarkers with predictive value of endometrial receptivity and found out the related lncRNA-mRNA network. The differential lncRNA-mRNA co-expression network revealed the potential regulatory roles of lncRNAs in endometrium of PCOS patients. The differentially expressed lncRNAs related to six key Go terms of mRNA were mainly involved in ATP metabolic process, oxidative phosphorylation, RNA catabolic process and response to corticosteroid, as well as response to steroid hormone and T cell activation. The altered lncRNA-mRNA network in endometrium of PCOS supported the hypothesis that impaired endometrial receptivity may play a critical role in implantation and pregnancy failure among PCOS patients.

A group of key mRNAs associated with altered abundance in the endometrium of PCOS women were related to ATP metabolic process. We also analyzed the co-expression module of ATP metabolic process related mRNA and differentially expressed lncRNAs. Energy balance is critical for the normal function of reproductive system. The metabolic abnormalities may contribute to the development of subfertility in PCOS. The prevalence of metabolic syndrome (MetS) in PCOS was 28.8% [22]. Altered fertility was commonly linked to metabolic dysfunctions including dyslipidemia and insulin resistance among PCOS women [23]. Abnormalities in pancreatic ATP synthase β subunit was found in mice with PCOS and type II diabetes comorbidity [24]. Besides, ATP inhibits human endometrial stem cell’s migration and proliferation [25] and mediates blastocyst-endometrium crosstalk in human [26]. These studies suggest that ATP metabolic processes may affect endometrial function in PCOS, which is consistent with our study. Some studies indicate that ATP release from luminal epithelial cells stimulates decidualization in mice via the P2Y2 receptor [27]. However, our study did not further investigate the specific mechanism. There were studies showed that resveratrol may improve endometrial function by improving ATP metabolism, restoring glycotic process and rehabilitating the number of granular cells [28]. Therefore, some drugs such as resveratrol may improve endometrial function through the process of ATP metabolism.

PCOS is associated with insulin resistance (IR) and altered muscle mitochondrial oxidative phosphorylation. Significant transcriptomic changes occurred in primary human endometrial stromal cells in a stepwise fashion. After embryo invasion, oxidative phosphorylation, mitochondrial organisation, and p53 signalling pathways were significantly altered in primary human endometrial stromal cells [29]. In our study a large proportion of differentially expressed mRNAs were involved in oxidative phosphorylation. Activation of oxidative phosphorylation in TP53-inactive endometrial carcinomas with a poor prognosis [30]. Maria M Szwarc revealed that SRC-2 knockdown reduces endometrial cancer cell proliferation and anchorage-independence [31]. SRC-2 can maintain cellular glycolytic capacity and oxidative phosphorylation, a process necessary for endometrial cancer cell proliferation. Both the metabolic and oxidative phosphorylation pathways are dysregulated in PCOS patients’ oocytes and cumulus cells [32]. Therefore, oxidative phosphorylation may be involved in the regulation of endometrial function.

The alteration of genes related to the RNA catabolic process in the endometrium of PCOS was showed in this study, and K H Sadek indicated that housekeeping genes were variable in stability in endometrium of healthy and PCOS women [33]. An increase in transcriptional regulation and mRNA stability was observed in PCOS patients with cholesterol side-chain cleavage gene expression [34]. Yuhua Z Farnell also indicated that the interaction between estradiol and selective modulators of its receptor could affect mRNA transcription and stability in human endometrial adenocarcinoma cells [35]. Therefore, altered expression of RNA catabolic process in endometrium from patients with PCOS may be related to the function of endometrium.

T cells play a crucial role in implantation and maintenance of pregnancy. The immunomodulatory mechanisms at the foetus-maternal interface remain unclear for this complex system. Understanding the role of T cells is a key element in understanding the endometrial immune system. T cells, the dominant lymphocytes in endometrium, could populate the decidua, but their precise function is unclear. Decidual CD4+ T (dCD4+ T) cells are essential for the induction and maintenance of maternal immune tolerance [36]. Decidual T cells may contribute to the maintenance of pregnancy by producing LIF, interleukin (IL)-4, IL-10 and M-CSF. T cells, which can produce LIF and IL-4, are also found in cumulus oophorus [37]. The activation and cytokine secretion levels of T cells in omental fat tissue and peripheral blood are linked to testosterone level and insulin resistance among PCOS women [38]. These findings suggest that in the pathogenesis of PCOS, metabolic changes in both CD4+ and CD8+ T cells that favour Th2 differentiation and glycolysis are important [39], and peripheral blood inflammatory-immune cells may serve as potential predictors of infertility in PCOS patients [40].

Aberrant endometrial receptivity in PCOS may result from altered expression of genes involved in steroid hormone synthesis. Corticosteroid and steroid hormone may affect the oocyte, the future embryo, and the endometrium. Expression profiling experiments using endometrium of PCOS patients in our study also provided evidence that corticosteroids and steroid hormones are important in the pathogenesis of PCOS endometrium. Hormones involved in human bone metabolism, including sex hormones, growth hormone and parathyroid hormone, show a disturbed pattern of production and secretion in PCOS [41]. Given the LH receptor expression in the endometrium [42, 43], high LH level in PCOS could directly influence endometrial pathophysiology. In high responders, decreased embryo implantation has been reported regardless of embryo quality, possibly due to a negative effect of supraphysiological circulating estradiol on the endometrium [44, 45]. Driven by steroid hormones, the cyclic changes of human endometrium during normal menstrual cycle are orchestrated by a plethora of epigenetically-regulated genes [46]. Corticosteroid signalling dysfunction in decidual cells has been linked to increased natural killer cell density in human endometrium during the periimplantation window [47].This study explored differences expression of corticosteroid and steroid hormone related genes between ovulation and PCOS women. Corticosteroid and steroid hormone profiling were different between ovulation and PCOS women.

Our study has the following limitations: [1] The heterogenic demographic and baseline characteristics of the two groups may introduce bias to finding interpretation. However, strict spatio-temporal restrictions on tissue sampling had been set to minimize other confounders; [2] We had a small sample size, but external validation among both PCOS and normal ovulatory patients were performed to verify the reliability of our findings; [3] We did not analyze the pregnancy outcomes of the included patients, since they were asked to use contraception for at least 1 month after endometrial biopsy. Future studies on pregnancy outcome are warranted for adequate interpretation of the GE changes we found.

The strength of our study was that, for the first time, we detected the pathophysiology changes in the endometirum of PCOS patients using genome-wide expression profiles at 3 days after oocyte retrieval, which is the time of cleavage embryo transfer. This study also identified lncRNA biomarkers with predictive value of endometrial receptivity and found out the related lncRNA-mRNA network. The differential lncRNA-mRNA co-expression network revealed the potential regulatory roles of lncRNAs in endometrium of PCOS patients, which provided a basis for the mechanism of endometrial receptivity in patients with PCOS, and partially served an explanation why PCOS women have an impaired reproductive outcome in clinic. This will provide the possibility to improve the pregnancy rate in patients with PCOS. Future studies should investigate the underlying mechanism, and lncRNAs may be developed as new potential diagnostic and therapeutic targets, which has important clinical implications.

Conclusion

Our results determined the characteristics and expression profile of endometrial in PCOS patients in pre-receptive phase. The possible pathways and related proteins of endometrial receptivity disorders were found, and lncRNAs may be developed as a predictive biomarker of endometrial receptivity.

Data availability

The datasets supporting the conclusions of this article are available in.

Gene Expression Omnibus GSE226146. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE226146.

References

  1. Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27(3):584–618.

    Article  CAS  PubMed  Google Scholar 

  2. Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20(2):235–44.

    Article  CAS  PubMed  Google Scholar 

  3. Evans J, Salamonsen LA, Winship A, Menkhorst E, Nie G, Gargett CE, Dimitriadis E. Fertile ground: human endometrial programming and lessons in health and disease. Nat Rev Endocrinol. 2016;12(11):654–67.

    Article  CAS  PubMed  Google Scholar 

  4. Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):575–92.

    Article  PubMed  Google Scholar 

  5. Qi Y, Yin Q, Gu J, Liu Y, Sun Q, Cao Y, Yan X, Yuan Y, Wu J. Elevated circulating levels of carnal ENST00000550337.1 are Associated with Polycystic Ovary Syndrome in Chinese women. Gynecol Obstet Invest. 2021;86(1–2):155–61.

    Article  CAS  PubMed  Google Scholar 

  6. Qin L, Huang CC, Yan XM, Wang Y, Li ZY, Wei XC. Long non-coding RNA H19 is associated with polycystic ovary syndrome in Chinese women: a preliminary study. Endocr J. 2019;66(7):587–95.

    Article  CAS  PubMed  Google Scholar 

  7. Zhang X, Xu Y, Fu L, Li D, Dai X, Liu L, Zhang J, Zheng L, Cui M. Identification of mRNAs related to endometrium function regulated by lncRNA CD36-005 in rat endometrial stromal cells. Reprod Biol Endocrinol. 2018;16(1):96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Qiao J, Wang L, Li R, Zhang X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod Biomed Online. 2008;17(3):425–35.

    Article  CAS  PubMed  Google Scholar 

  9. Kenigsberg S, Bentov Y, Chalifa-Caspi V, Potashnik G, Ofir R, Birk OS. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod. 2009;15(2):89–103.

    Article  CAS  PubMed  Google Scholar 

  10. Savaris RF, Groll JM, Young SL, DeMayo FJ, Jeong JW, Hamilton AE, Giudice LC, Lessey BA. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles. J Clin Endocrinol Metab. 2011;96(6):1737–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wei L, Xin C, Wang W, Hao C. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction. Gene. 2018;661:85–94.

    Article  CAS  PubMed  Google Scholar 

  12. Ponnampalam AP, Weston GC, Trajstman AC, Susil B, Rogers PA. Molecular classification of human endometrial cycle stages by transcriptional profiling. Mol Hum Reprod. 2004;10(12):879–93.

    Article  CAS  PubMed  Google Scholar 

  13. Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, Phillips SC, Smith SK. Determination of the transcript profile of human endometrium. Mol Hum Reprod. 2003;9(1):19–33.

    Article  CAS  PubMed  Google Scholar 

  14. Mirkin S, Nikas G, Hsiu JG, Díaz J, Oehninger S. Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab. 2004;89(11):5742–52.

    Article  CAS  PubMed  Google Scholar 

  15. Horcajadas JA, Riesewijk A, Polman J, van Os R, Pellicer A, Mosselman S, Simón C. Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod. 2005;11(3):195–205.

    Article  CAS  PubMed  Google Scholar 

  16. Simon C, Oberyé J, Bellver J, Vidal C, Bosch E, Horcajadas JA, Murphy C, Adams S, Riesewijk A, Mannaerts B, Pellicer A. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod (Oxford England). 2005;20(12):3318–27.

    Article  CAS  Google Scholar 

  17. Al-Inany H, Aboulghar MA, Mansour RT, Serour GI. Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol. Reprod Biomed Online. 2005;10(5):567–70.

    Article  CAS  PubMed  Google Scholar 

  18. Parkhomchuk D, Borodina T, Amstislavskiy V, Banaru M, Hallen L, Krobitsch S, Lehrach H, Soldatov A. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res 2009, 37, (18), e123.

  19. Shumate A, Wong B, Pertea G, Pertea M. Improved transcriptome assembly using a hybrid of long and short reads with StringTie. PLoS Comput Biol 2022, 18, (6), e1009730.

  20. Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587–d592.

    Article  CAS  PubMed  Google Scholar 

  21. Niwa K, Imai A, Hashimoto M, Yokoyama Y, Mori H, Matsuda Y, Tamaya T. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep. 2000;7(1):89–93.

    CAS  PubMed  Google Scholar 

  22. Zahiri Z, Sharami SH, Milani F, Mohammadi F, Kazemnejad E, Ebrahimi H, Dalil Heirati SF. Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertility Steril. 2016;9(4):490–6.

    CAS  Google Scholar 

  23. Tosca L, Chabrolle C, Dupont J. [AMPK: a link between metabolism and reproduction?]. Med Sciences: M/S. 2008;24(3):297–300.

    Google Scholar 

  24. Li W, Li SJ, Yin TL, Yang J, Cheng Y. ATP synthase β-subunit abnormality in pancreas islets of rats with polycystic ovary syndrome and type 2 diabetes mellitus. J Huazhong Univ Sci Technol Med Sci = Hua Zhong Ke Ji Da Xue Xue bao Yi Xue Ying De Wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2017;37(2):210–6.

    Article  CAS  Google Scholar 

  25. Semenova S, Shatrova A, Vassilieva I, Shamatova M, Pugovkina N, Negulyaev Y. Adenosine-5’-triphosphate suppresses proliferation and migration capacity of human endometrial stem cells. J Cell Mol Med. 2020;24(8):4580–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gu XW, Yang Y, Li T, Chen ZC, Fu T, Pan JM, Ou JP, Yang ZM. ATP mediates the interaction between human blastocyst and endometrium. Cell Prolif 2020, 53, (2), e12737.

  27. Gu XW, Chen ZC, Yang ZS, Yang Y, Yan YP, Liu YF, Pan JM, Su RW, Yang ZM. Blastocyst-induced ATP release from luminal epithelial cells initiates decidualization through the P2Y2 receptor in mice. Science signaling 2020, 13, (646).

  28. Liang A, Huang L, Liu H, He W, Lei X, Li M, Li S, Liang H, Chen G, Tang J, Chen F, Cao X, Wang Y, Shen X, Chen X. Resveratrol improves Follicular Development of PCOS rats by regulating the glycolytic pathway. Mol Nutr Food Res 2021, 65, (24), e2100457.

  29. Han S, Liu M, Liu S, Li Y. Transcriptomic analysis of human endometrial stromal cells during early embryo invasion. Ann Med. 2021;53(1):1758–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Takahashi N, Hatakeyama K, Nagashima T, Ohshima K, Urakami K, Yamaguchi K, Hirashima Y. Activation of oxidative phosphorylation in TP53-inactive endometrial carcinomas with a poor prognosis. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2021;31(12):1557–63.

    Article  Google Scholar 

  31. Szwarc MM, Hai L, Gibbons WE, White LD, Mo Q, Kommagani R, Lanz RB, DeMayo FJ, O’Malley BW, Lydon JP. Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics. Reproduction. 2018;156(5):387–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Li J, Chen H, Gou M, Tian C, Wang H, Song X, Keefe DL, Bai X, Liu L. Molecular features of polycystic ovary syndrome revealed by Transcriptome Analysis of Oocytes and Cumulus cells. Front cell Dev Biology. 2021;9:735684.

    Article  Google Scholar 

  33. Sadek KH, Cagampang FR, Bruce KD, Shreeve N, Macklon N, Cheong Y. Variation in stability of housekeeping genes in endometrium of healthy and polycystic ovarian syndrome women. Hum Reprod (Oxford England). 2012;27(1):251–6.

    Article  CAS  Google Scholar 

  34. Wickenheisser JK, Biegler JM, Nelson-Degrave VL, Legro RS, Strauss JF 3rd;, McAllister JM. Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS ONE 2012, 7, (11), e48963.

  35. Farnell YZ, Ing NH. The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol. 2003;84(4):453–61.

    Article  CAS  PubMed  Google Scholar 

  36. Chen L, Li M, Sun F, Qian J, Du M, Wang S, Li D. Eomesodermin regulate decidual CD4(+)T cell function during human early pregnancy. J Reprod Immunol. 2021;146:103290.

    Article  CAS  PubMed  Google Scholar 

  37. Piccinni MP. T-cell cytokines in pregnancy. American journal of reproductive immunology (New York, N.Y.: 1989) 2002, 47, (5), 289– 94.

  38. Juan CC, Chen KH, Chen CW, Ho CH, Wang PH, Chen HS, Hwang JL, Lin YH, Seow KM. Increased regulated on activation, normal T-cell expressed and secreted levels and cysteine-cysteine chemokine receptor 5 upregulation in omental adipose tissue and peripheral blood mononuclear cells are associated with testosterone level and insulin resistance in polycystic ovary syndrome. Fertil Steril. 2021;116(4):1139–46.

    Article  CAS  PubMed  Google Scholar 

  39. Nasri F, Zare M, Doroudchi M, Gharesi-Fard B. Proteome Analysis of CD4(+) T cells reveals differentially expressed proteins in infertile polycystic ovary syndrome patients. Endocr Metab Immune Disord Drug Targets. 2021;21(11):1998–2004.

    Article  CAS  PubMed  Google Scholar 

  40. He S, Mao X, Lei H, Dong B, Guo D, Zheng B, Sun P. Peripheral blood inflammatory-Immune cells as a predictor of infertility in women with polycystic ovary syndrome. J Inflamm Res. 2020;13:441–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Krishnan A, Muthusami S. Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol. 2017;232(2):R99–r113.

    Article  CAS  PubMed  Google Scholar 

  42. Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70(2):421–30.

    Article  CAS  PubMed  Google Scholar 

  43. Shemesh M. Actions of gonadotrophins on the uterus. Reproduction. 2001;121(6):835–42.

    Article  CAS  PubMed  Google Scholar 

  44. Simón C, Cano F, Valbuena D, Remohí J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod (Oxford England). 1995;10(9):2432–7.

    Article  Google Scholar 

  45. Chen QJ, Sun XX, Li L, Gao XH, Wu Y, Gemzell-Danielsson K, Cheng LN. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta Obstet Gynecol Scand. 2007;86(7):849–54.

    Article  CAS  PubMed  Google Scholar 

  46. Guo SW. The endometrial epigenome and its response to steroid hormones. Mol Cell Endocrinol. 2012;358(2):185–96.

    Article  CAS  PubMed  Google Scholar 

  47. Kuroda K, Venkatakrishnan R, James S, Šucurovic S, Mulac-Jericevic B, Lucas ES, Takeda S, Shmygol A, Brosens JJ, Quenby S. Elevated periimplantation uterine natural killer cell density in human endometrium is associated with impaired corticosteroid signaling in decidualizing stromal cells. J Clin Endocrinol Metab. 2013;98(11):4429–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank all the patients who participated in this study.

Funding

This study was supported by Hebei Natural Science Foundation (H2022206019). S&T Program of Hebei (21377721D, 21377720D). Medical Science Research Project of Hebei Province (20211494, 20240414). National Key R&D Program of China(2021YFC2700605). Innovation Capability Enhancement Program of Hebei Province (Hebei Clinical Medical Research Center Special Project) (20577710D). Hebei Provincial Government Funded Clinical Medicine Excellent Talent Program (2021). Science Foundation Project of The Second Hospital of Hebei Medical University (2HN202408).

Author information

Author notes

  1. Xiuhua Xu and Aimin Yang contributed equally to this work.

Authors and Affiliations

  1. Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Hebei Medical Key Discipline of Reproductive Medicine, Hebei Collaborative Innovation Center of Integrated Traditional and Western Medicine on Reproductive Disease, Department of Reproductive Medicine, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China

    Xiuhua Xu, Aimin Yang, Pengxiang Tian, Kun Zhang, Yuanyuan Liu, Yizhuo Wang, Ziwei Wang, Yanjing Wu, Zhiming Zhao, Baojun shi & Gui-min Hao

  2. Department of Gynecology and Obstetrics, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China

    Aimin Yang & Xianghua Huang

  3. Cardiovascular platform, Institute of Health and Disease, Hebei Medical University, Shijiazhuang, 050000, China

    Xiuhua Xu & Qian Li

Authors
  1. Xiuhua Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aimin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pengxiang Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuanyuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yizhuo Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ziwei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yanjing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhiming Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Qian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Baojun shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xianghua Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Gui-min Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization, XH.X. and AM.Y.; methodology, XH.X.,PX.T. and K.Z.; software, YY.L.; validation,YZ.W., ZW.W., and YJ.W.; formal analysis, XH.X.and AM.Y.; investigation, ZM.Z. and Q.L.; resources, XH.X.and AM.Y.; data curation, XH.X.; writing—original draft preparation, XH.X.; writing—review and editing, GM.H.; visualization, XH.X.; supervision, GM.H.and XH.H.; project administration, BJ.S.; funding acquisition, XH.X.,GM.H.,BJ.S. All authors have read and agreed to the published version of the manuscript.

Corresponding authors

Correspondence to Xianghua Huang or Gui-min Hao.

Ethics declarations

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Ethics approval and consent to participate

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Second Hospital of Hebei Medical University (Ethics No. 2018-R028). Informed consents were obtained from the participants/patients involved in this study.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Yang, A., Tian, P. et al. Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer. BMC Med Genomics 17, 26 (2024). https://doi.org/10.1186/s12920-024-01806-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12920-024-01806-w

Keywords

BMC Medical Genomics

ISSN: 1755-8794

Contact us